LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 8 of total 8

Search options

  1. Article ; Online: Treating facial overfilled syndrome with impaired facial expression-Presenting clinical experience with ultrasound imaging.

    Schelke, Leonie / Harris, Steven / Cartier, Hugues / Alfertshofer, Michael / Doestzada, Marwah / Cotofana, Sebastian / Velthuis, Peter J

    Journal of cosmetic dermatology

    2023  Volume 22, Issue 12, Page(s) 3252–3260

    Abstract: Background: Facial overfilled syndrome is an adverse event following minimally invasive soft tissue filler injections. It presents in most cases as excess midfacial volume and/or as unnatural smile which is difficult to detect due to the absence of ... ...

    Abstract Background: Facial overfilled syndrome is an adverse event following minimally invasive soft tissue filler injections. It presents in most cases as excess midfacial volume and/or as unnatural smile which is difficult to detect due to the absence of standardized evaluation methods.
    Objective: To showcase how to identify, evaluate, and treat facial overfilled syndrome by utilizing facial ultrasound and simultaneous hyaluronidase injections.
    Methods: Twenty-eight consecutive patients (26 females, 2 males) were enrolled in this study in which facial ultrasound was performed to evaluate the location previously implanted filler material. The position of the oral commissure was objectively measured in relation to bony landmarks, and the severity of lateral canthal lines was assessed by independent and blinded raters.
    Results: The material was identified in 35.7% inside the subdermal fatty layer, in 28.6% inside the deep supra-periosteal fatty layer, in 10.7% inside the fibrous layer deep to the subdermal fatty layer, whereas in 25.0%, the product was not possible to locate clearly inside one specific layer. On average, 81.6 I.U. [range: 75-150] of hyaluronidase were injected. Lateral canthal line severity was before the treatment 2.28 (1.4) and was after the hyaluronidase treatment 2.02 (1.3) with p = 0.578. The position of the oral commissure increased by 0.60 cm in vertical and by 0.30 cm in horizontal directions (both p < 0.001).
    Conclusion: Facial overfilled syndrome following aesthetic soft tissue filler injections can present as excess midfacial volume but also as unnatural smile. Targeted hyaluronidase injections into the culprit pockets inside the midfacial soft tissues have shown to re-establish a natural smile, to reduce excess midfacial volume, and to decrease lateral canthal line severity.
    MeSH term(s) Male ; Female ; Humans ; Facial Expression ; Hyaluronoglucosaminidase ; Face/diagnostic imaging ; Lip ; Injections ; Dermal Fillers/adverse effects ; Cosmetic Techniques/adverse effects
    Chemical Substances Hyaluronoglucosaminidase (EC 3.2.1.35) ; Dermal Fillers
    Language English
    Publishing date 2023-09-29
    Publishing country England
    Document type Journal Article
    ZDB-ID 2280551-5
    ISSN 1473-2165 ; 1473-2130
    ISSN (online) 1473-2165
    ISSN 1473-2130
    DOI 10.1111/jocd.16013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Reduced voluntary drive during sustained but not during brief maximal voluntary contractions in the first dorsal interosseous weakened by spinal cord injury.

    Prak, Roeland F / Doestzada, Marwah / Thomas, Christine K / Tepper, Marga / Zijdewind, Inge

    Journal of applied physiology (Bethesda, Md. : 1985)

    2015  Volume 119, Issue 11, Page(s) 1320–1329

    Abstract: In able-bodied (AB) individuals, voluntary muscle activation progressively declines during sustained contractions. However, few data are available on voluntary muscle activation during sustained contractions in muscles weakened by spinal cord injury (SCI) ...

    Abstract In able-bodied (AB) individuals, voluntary muscle activation progressively declines during sustained contractions. However, few data are available on voluntary muscle activation during sustained contractions in muscles weakened by spinal cord injury (SCI), where greater force declines may limit task performance. SCI-related impairment of muscle activation complicates interpretation of the interpolated twitch technique commonly used to assess muscle activation. We attempted to estimate and correct for the SCI-related-superimposed twitch. Seventeen participants, both AB and with SCI (American Spinal Injury Association Impairment Scale C/D) produced brief and sustained (2-min) maximal voluntary contractions (MVCs) with the first dorsal interosseous. Force and electromyography were recorded together with superimposed (doublet) twitches. MVCs of participants with SCI were weaker than those of AB participants (20.3 N, SD 7.1 vs. 37.9 N, SD 9.5; P < 0.001); MVC-superimposed twitches were larger in participants with SCI (SCI median 10.1%, range 2.0-63.2%; AB median 4.7%, range 0.0-18.4% rest twitch; P = 0.007). No difference was found after correction for the SCI-related-superimposed twitch (median 6.7%, 0.0-17.5% rest twitch, P = 0.402). Thus during brief contractions, the maximal corticofugal output that participants with SCI could exert was similar to that of AB participants. During the sustained contraction, force decline (SCI, 58.0%, SD 15.1; AB, 57.2% SD 13.3) was similar (P = 0.887) because participants with SCI developed less peripheral (P = 0.048) but more central fatigue than AB participants. The largest change occurred at the start of the sustained contraction when the (corrected) superimposed twitches increased more in participants with SCI (SCI, 16.3% rest twitch, SD 20.8; AB, 2.7%, SD 4.7; P = 0.01). The greater reduction in muscle activation after SCI may relate to a reduced capacity to overcome fast fatigue-related excitability changes at the spinal level.
    MeSH term(s) Adult ; Atrophy ; Drive ; Electric Stimulation ; Electromyography ; Female ; Humans ; Male ; Middle Aged ; Muscle Contraction ; Muscle Fatigue ; Muscle, Skeletal/metabolism ; Muscle, Skeletal/pathology ; Muscle, Skeletal/physiopathology ; Psychomotor Performance ; Spinal Cord Injuries/metabolism ; Spinal Cord Injuries/physiopathology
    Language English
    Publishing date 2015-12-01
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 219139-8
    ISSN 1522-1601 ; 0021-8987 ; 0161-7567 ; 8750-7587
    ISSN (online) 1522-1601
    ISSN 0021-8987 ; 0161-7567 ; 8750-7587
    DOI 10.1152/japplphysiol.00399.2015
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Characterization of gut microbial structural variations as determinants of human bile acid metabolism.

    Wang, Daoming / Doestzada, Marwah / Chen, Lianmin / Andreu-Sánchez, Sergio / van den Munckhof, Inge C L / Augustijn, Hannah E / Koehorst, Martijn / Ruiz-Moreno, Angel J / Bloks, Vincent W / Riksen, Niels P / Rutten, Joost H W / Joosten, Leo A B / Netea, Mihai G / Wijmenga, Cisca / Zhernakova, Alexandra / Kuipers, Folkert / Fu, Jingyuan

    Cell host & microbe

    2021  Volume 29, Issue 12, Page(s) 1802–1814.e5

    Abstract: Bile acids (BAs) facilitate intestinal fat absorption and act as important signaling molecules in host-gut microbiota crosstalk. BA-metabolizing pathways in the microbial community have been identified, but it remains largely unknown how the highly ... ...

    Abstract Bile acids (BAs) facilitate intestinal fat absorption and act as important signaling molecules in host-gut microbiota crosstalk. BA-metabolizing pathways in the microbial community have been identified, but it remains largely unknown how the highly variable genomes of gut bacteria interact with host BA metabolism. We characterized 8,282 structural variants (SVs) of 55 bacterial species in the gut microbiomes of 1,437 individuals from two cohorts and performed a systematic association study with 39 plasma BA parameters. Both variations in SV-based continuous genetic makeup and discrete clusters showed correlations with BA metabolism. Metagenome-wide association analysis identified 809 replicable associations between bacterial SVs and BAs and SV regulators that mediate the effects of lifestyle factors on BA metabolism. This is the largest microbial genetic association analysis to demonstrate the impact of bacterial SVs on human BA composition, and it highlights the potential of targeting gut microbiota to regulate BA metabolism through lifestyle intervention.
    MeSH term(s) Bacteria/genetics ; Bile Acids and Salts/metabolism ; Gastrointestinal Microbiome/genetics ; Gastrointestinal Microbiome/physiology ; Humans ; Life Style ; Lipid Metabolism ; Metagenome ; Microbiota ; Obesity ; Signal Transduction
    Chemical Substances Bile Acids and Salts
    Language English
    Publishing date 2021-11-29
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2278004-X
    ISSN 1934-6069 ; 1931-3128
    ISSN (online) 1934-6069
    ISSN 1931-3128
    DOI 10.1016/j.chom.2021.11.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Pharmacomicrobiomics: a novel route towards personalized medicine?

    Doestzada, Marwah / Vila, Arnau Vich / Zhernakova, Alexandra / Koonen, Debby P Y / Weersma, Rinse K / Touw, Daan J / Kuipers, Folkert / Wijmenga, Cisca / Fu, Jingyuan

    Protein & cell

    2018  Volume 9, Issue 5, Page(s) 432–445

    Abstract: Inter-individual heterogeneity in drug response is a serious problem that affects the patient's wellbeing and poses enormous clinical and financial burdens on a societal level. Pharmacogenomics has been at the forefront of research into the impact of ... ...

    Abstract Inter-individual heterogeneity in drug response is a serious problem that affects the patient's wellbeing and poses enormous clinical and financial burdens on a societal level. Pharmacogenomics has been at the forefront of research into the impact of individual genetic background on drug response variability or drug toxicity, and recently the gut microbiome, which has also been called the second genome, has been recognized as an important player in this respect. Moreover, the microbiome is a very attractive target for improving drug efficacy and safety due to the opportunities to manipulate its composition. Pharmacomicrobiomics is an emerging field that investigates the interplay of microbiome variation and drugs response and disposition (absorption, distribution, metabolism and excretion). In this review, we provide a historical overview and examine current state-of-the-art knowledge on the complex interactions between gut microbiome, host and drugs. We argue that combining pharmacogenomics and pharmacomicrobiomics will provide an important foundation for making major advances in personalized medicine.
    MeSH term(s) Anti-Infective Agents/pharmacology ; Biodiversity ; Humans ; Microbiota ; Pharmacogenetics ; Precision Medicine ; Toxicogenetics
    Chemical Substances Anti-Infective Agents
    Language English
    Publishing date 2018-04-28
    Publishing country Germany
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2543451-2
    ISSN 1674-8018 ; 1674-8018
    ISSN (online) 1674-8018
    ISSN 1674-8018
    DOI 10.1007/s13238-018-0547-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Genetic and Microbial Associations to Plasma and Fecal Bile Acids in Obesity Relate to Plasma Lipids and Liver Fat Content.

    Chen, Lianmin / van den Munckhof, Inge C L / Schraa, Kiki / Ter Horst, Rob / Koehorst, Martijn / van Faassen, Martijn / van der Ley, Claude / Doestzada, Marwah / Zhernakova, Daria V / Kurilshikov, Alexander / Bloks, Vincent W / Groen, Albert K / Riksen, Niels P / Rutten, Joost H W / Joosten, Leo A B / Wijmenga, Cisca / Zhernakova, Alexandra / Netea, Mihai G / Fu, Jingyuan /
    Kuipers, Folkert

    Cell reports

    2020  Volume 33, Issue 1, Page(s) 108212

    Abstract: Bile acids (BAs) are implicated in the etiology of obesity-related conditions such as non-alcoholic fatty liver disease. Differently structured BA species display variable signaling activities via farnesoid X receptor (FXR) and Takeda G protein-coupled ... ...

    Abstract Bile acids (BAs) are implicated in the etiology of obesity-related conditions such as non-alcoholic fatty liver disease. Differently structured BA species display variable signaling activities via farnesoid X receptor (FXR) and Takeda G protein-coupled BA receptor 1 (TGR5). This study profiles plasma and fecal BAs and plasma 7α-hydroxy-4-cholesten-3-one (C4) in 297 persons with obesity, identifies underlying genetic and microbial determinants, and establishes BA correlations with liver fat and plasma lipid parameters. We identify 27 genetic associations (p < 5 × 10
    MeSH term(s) Aged ; Aged, 80 and over ; Bile Acids and Salts/physiology ; Humans ; Lipid Metabolism/genetics ; Liver/pathology ; Metabolic Syndrome/physiopathology ; Middle Aged ; Obesity/physiopathology
    Chemical Substances Bile Acids and Salts
    Language English
    Publishing date 2020-10-07
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2649101-1
    ISSN 2211-1247 ; 2211-1247
    ISSN (online) 2211-1247
    ISSN 2211-1247
    DOI 10.1016/j.celrep.2020.108212
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Cholangiopathy and Biliary Fibrosis in Cyp2c70-Deficient Mice Are Fully Reversed by Ursodeoxycholic Acid.

    de Boer, Jan Freark / de Vries, Hilde D / Palmiotti, Anna / Li, Rumei / Doestzada, Marwah / Hoogerland, Joanne A / Fu, Jingyuan / La Rose, Anouk M / Westerterp, Marit / Mulder, Niels L / Hovingh, Milaine V / Koehorst, Martijn / Kloosterhuis, Niels J / Wolters, Justina C / Bloks, Vincent W / Haas, Joel T / Dombrowicz, David / Staels, Bart / van de Sluis, Bart /
    Kuipers, Folkert

    Cellular and molecular gastroenterology and hepatology

    2020  Volume 11, Issue 4, Page(s) 1045–1069

    Abstract: Background and aims: Bile acids (BAs) aid intestinal fat absorption and exert systemic actions by receptor-mediated signaling. BA receptors have been identified as drug targets for liver diseases. Yet, differences in BA metabolism between humans and ... ...

    Abstract Background and aims: Bile acids (BAs) aid intestinal fat absorption and exert systemic actions by receptor-mediated signaling. BA receptors have been identified as drug targets for liver diseases. Yet, differences in BA metabolism between humans and mice hamper translation of pre-clinical outcomes. Cyp2c70-ablation in mice prevents synthesis of mouse/rat-specific muricholic acids (MCAs), but potential (patho)physiological consequences of their absence are unknown. We therefore assessed age- and gender-dependent effects of Cyp2c70-deficiency in mice.
    Methods: The consequences of Cyp2c70-deficiency were assessed in male and female mice at different ages.
    Results: Cyp2c70
    Conclusion: Cyp2c70
    MeSH term(s) Animals ; Bile Acids and Salts/metabolism ; Biliary Tract Diseases/etiology ; Biliary Tract Diseases/metabolism ; Biliary Tract Diseases/pathology ; Biliary Tract Diseases/prevention & control ; Cholangitis/etiology ; Cholangitis/metabolism ; Cholangitis/pathology ; Cholangitis/prevention & control ; Cholic Acids/metabolism ; Cytochrome P-450 Enzyme System/physiology ; Female ; Fibrosis/etiology ; Fibrosis/metabolism ; Fibrosis/pathology ; Fibrosis/prevention & control ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Ursodeoxycholic Acid/pharmacology
    Chemical Substances Bile Acids and Salts ; Cholic Acids ; muricholic acid (39016-49-4) ; Ursodeoxycholic Acid (724L30Y2QR) ; Cytochrome P-450 Enzyme System (9035-51-2) ; cytochrome P-450 2C70, mouse (EC 1.-)
    Language English
    Publishing date 2020-12-10
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2819778-1
    ISSN 2352-345X ; 2352-345X
    ISSN (online) 2352-345X
    ISSN 2352-345X
    DOI 10.1016/j.jcmgh.2020.12.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Pharmacomicrobiomics

    Marwah Doestzada / Arnau Vich Vila / Alexandra Zhernakova / Debby P. Y. Koonen / Rinse K. Weersma / Daan J. Touw / Folkert Kuipers / Cisca Wijmenga / Jingyuan Fu

    Protein & Cell, Vol 9, Iss 5, Pp 432-

    a novel route towards personalized medicine?

    2018  Volume 445

    Abstract: ABSTRACT Inter-individual heterogeneity in drug response is a serious problem that affects the patient’s wellbeing and poses enormous clinical and financial burdens on a societal level. Pharmacogenomics has been at the forefront of research into the ... ...

    Abstract ABSTRACT Inter-individual heterogeneity in drug response is a serious problem that affects the patient’s wellbeing and poses enormous clinical and financial burdens on a societal level. Pharmacogenomics has been at the forefront of research into the impact of individual genetic background on drug response variability or drug toxicity, and recently the gut microbiome, which has also been called the second genome, has been recognized as an important player in this respect. Moreover, the microbiome is a very attractive target for improving drug efficacy and safety due to the opportunities to manipulate its composition. Pharmacomicrobiomics is an emerging field that investigates the interplay of microbiome variation and drugs response and disposition (absorption, distribution, metabolism and excretion). In this review, we provide a historical overview and examine current state-of-the-art knowledge on the complex interactions between gut microbiome, host and drugs. We argue that combining pharmacogenomics and pharmacomicrobiomics will provide an important foundation for making major advances in personalized medicine.
    Keywords gut microbiome ; drug metabolism ; personalized medicine ; Cytology ; QH573-671 ; Animal biochemistry ; QP501-801
    Language English
    Publishing date 2018-04-01T00:00:00Z
    Publisher SpringerOpen
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article ; Online: Genetic and Microbial Associations to Plasma and Fecal Bile Acids in Obesity Relate to Plasma Lipids and Liver Fat Content

    Lianmin Chen / Inge C.L. van den Munckhof / Kiki Schraa / Rob ter Horst / Martijn Koehorst / Martijn van Faassen / Claude van der Ley / Marwah Doestzada / Daria V. Zhernakova / Alexander Kurilshikov / Vincent W. Bloks / Albert K. Groen / Niels P. Riksen / Joost H.W. Rutten / Leo A.B. Joosten / Cisca Wijmenga / Alexandra Zhernakova / Mihai G. Netea / Jingyuan Fu /
    Folkert Kuipers

    Cell Reports, Vol 33, Iss 1, Pp 108212- (2020)

    2020  

    Abstract: Summary: Bile acids (BAs) are implicated in the etiology of obesity-related conditions such as non-alcoholic fatty liver disease. Differently structured BA species display variable signaling activities via farnesoid X receptor (FXR) and Takeda G protein- ... ...

    Abstract Summary: Bile acids (BAs) are implicated in the etiology of obesity-related conditions such as non-alcoholic fatty liver disease. Differently structured BA species display variable signaling activities via farnesoid X receptor (FXR) and Takeda G protein-coupled BA receptor 1 (TGR5). This study profiles plasma and fecal BAs and plasma 7α-hydroxy-4-cholesten-3-one (C4) in 297 persons with obesity, identifies underlying genetic and microbial determinants, and establishes BA correlations with liver fat and plasma lipid parameters. We identify 27 genetic associations (p < 5 × 10−8) and 439 microbial correlations (FDR < 0.05) for 50 BA entities. Additionally, we report 111 correlations between BA and 88 lipid parameters (FDR < 0.05), mainly for C4 reflecting hepatic BA synthesis. Inter-individual variability in the plasma BA profile does not reflect hepatic BA synthetic pathways, but rather transport and metabolism within the enterohepatic circulation. Our study reveals genetic and microbial determinants of BAs in obesity and their relationship to disease-relevant lipid parameters that are important for the design of personalized therapies targeting BA-signaling pathways.
    Keywords bile acids ; genetics ; gut microbiome ; liver ; enterohepatic circulation ; obesity ; Biology (General) ; QH301-705.5
    Subject code 571
    Language English
    Publishing date 2020-10-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top